QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
(par value of $0.01 per share) |
ý | Accelerated Filer | ☐ | ||||||||||||||||||
Non-accelerated filer | ¨ | Smaller reporting company | ||||||||||||||||||
Emerging growth company |
Page | ||||||||
PART I. | ||||||||
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
PART II. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 6. | ||||||||
Item 1. | Financial Statements |
January 31, 2022 | October 31, 2021* | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Short-term investments | |||||||||||
Total cash, cash equivalents and short-term investments | |||||||||||
Accounts receivable, net | |||||||||||
Inventories, net | |||||||||||
Prepaid and other current assets | |||||||||||
Total current assets | |||||||||||
Property and equipment, net | |||||||||||
Operating lease right-of-use assets, net | |||||||||||
Goodwill | |||||||||||
Intangible assets, net | |||||||||||
Deferred income taxes | |||||||||||
Other long-term assets | |||||||||||
Total assets | $ | $ | |||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable and accrued liabilities | $ | $ | |||||||||
Operating lease liabilities, current | |||||||||||
Deferred revenue | |||||||||||
Short-term debt | |||||||||||
Total current liabilities | |||||||||||
Operating lease liabilities, non-current | |||||||||||
Long-term deferred revenue | |||||||||||
Long-term debt | |||||||||||
Other long-term liabilities | |||||||||||
Total liabilities | |||||||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $ | |||||||||||
Common stock, $ | |||||||||||
Capital in excess of par value | |||||||||||
Retained earnings | |||||||||||
Treasury stock, at cost: | ( | ( | |||||||||
Accumulated other comprehensive income (loss) | ( | ( | |||||||||
Total Synopsys stockholders’ equity | |||||||||||
Non-controlling interest | |||||||||||
Total stockholders’ equity | |||||||||||
Total liabilities and stockholders’ equity | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
Revenue: | |||||||||||
Time-based products | $ | $ | |||||||||
Upfront products | |||||||||||
Maintenance and service | |||||||||||
Total revenue | |||||||||||
Cost of revenue: | |||||||||||
Products | |||||||||||
Maintenance and service | |||||||||||
Amortization of intangible assets | |||||||||||
Total cost of revenue | |||||||||||
Gross margin | |||||||||||
Operating expenses: | |||||||||||
Research and development | |||||||||||
Sales and marketing | |||||||||||
General and administrative | |||||||||||
Amortization of intangible assets | |||||||||||
Restructuring charges | |||||||||||
Total operating expenses | |||||||||||
Operating income | |||||||||||
Other income (expense), net | ( | ||||||||||
Income before income taxes | |||||||||||
Provision for income taxes | |||||||||||
Net income | $ | $ | |||||||||
Net income (loss) attributed to non-controlling interest | ( | ( | |||||||||
Net income attributed to Synopsys | $ | $ | |||||||||
Net income per share attributed to Synopsys: | |||||||||||
Basic | $ | $ | |||||||||
Diluted | $ | $ | |||||||||
Shares used in computing per share amounts: | |||||||||||
Basic | |||||||||||
Diluted |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
Net income | $ | $ | |||||||||
Other comprehensive income (loss): | |||||||||||
Change in foreign currency translation adjustment | ( | ||||||||||
Changes in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented | ( | ||||||||||
Cash flow hedges: | |||||||||||
Deferred gains (losses), net of tax $ | ( | ||||||||||
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $( | ( | ||||||||||
Other comprehensive income (loss), net of tax effects | ( | ||||||||||
Comprehensive income | |||||||||||
Less: net income (loss) attributed to non-controlling interest | ( | ( | |||||||||
Comprehensive income attributed to Synopsys | $ | $ |
Capital in Excess of Par Value | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Synopsys Stockholders’ Equity | Non-controlling Interest | Stockholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at October 31, 2021 | $ | $ | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Net income | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax effects | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Equity forward contract, net | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued, net of shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 31, 2022 | $ | $ | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Capital in Excess of Par Value | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Synopsys Stockholders’ Equity | Non-controlling Interest | Stockholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at October 31, 2020 | $ | $ | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Net income | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Retained earnings adjustment due to adoption of ASC 326(1) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax effects | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Equity forward contract, net | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued, net of shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 31, 2021 | $ | $ | $ | $ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income attributed to Synopsys | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Amortization and depreciation | |||||||||||
Reduction of operating lease right-of-use assets | |||||||||||
Amortization of capitalized costs to obtain revenue contracts | |||||||||||
Stock-based compensation | |||||||||||
Allowance for credit losses | |||||||||||
Deferred income taxes | ( | ( | |||||||||
Other non-cash | ( | ||||||||||
Net changes in operating assets and liabilities, net of acquired assets and liabilities: | |||||||||||
Accounts receivable | ( | ( | |||||||||
Inventories | ( | ||||||||||
Prepaid and other current assets | ( | ( | |||||||||
Other long-term assets | ( | ( | |||||||||
Accounts payable and accrued liabilities | ( | ( | |||||||||
Operating lease liabilities | ( | ( | |||||||||
Income taxes | |||||||||||
Deferred revenue | |||||||||||
Net cash provided by operating activities | |||||||||||
Cash flows from investing activities: | |||||||||||
Proceeds from sales and maturities of short-term investments | |||||||||||
Purchases of short-term investments | ( | ||||||||||
Proceeds from sales of long-term investments | |||||||||||
Purchases of long-term investments | ( | ||||||||||
Purchases of property and equipment | ( | ( | |||||||||
Cash paid for acquisitions, net of cash acquired | ( | ( | |||||||||
Capitalization of software development costs | ( | ( | |||||||||
Other | ( | ||||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Repayment of debt | ( | ( | |||||||||
Issuances of common stock | |||||||||||
Payments for taxes related to net share settlement of equity awards | ( | ( | |||||||||
Purchase of equity forward contract | ( | ( | |||||||||
Purchases of treasury stock | ( | ( | |||||||||
Other | ( | ||||||||||
Net cash used in financing activities | ( | ( | |||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ( | ||||||||||
Net change in cash, cash equivalents and restricted cash | ( | ( | |||||||||
Cash, cash equivalents and restricted cash, beginning of year | |||||||||||
Cash, cash equivalents and restricted cash, end of period | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
EDA | % | % | |||||||||
IP & System Integration | % | % | |||||||||
Software Integrity Products & Services | % | % | |||||||||
Other | % | % | |||||||||
Total | % | % |
As of | |||||||||||
January 31, 2022 | October 31, 2021 | ||||||||||
(in thousands) | |||||||||||
Contract assets, net | $ | $ | |||||||||
Unbilled receivables | $ | $ | |||||||||
Deferred revenue | $ | $ |
(in thousands) | |||||
Balance at October 31, 2021 | $ | ||||
Additions | |||||
Adjustments | |||||
Effect of foreign currency translation | ( | ||||
Balance at January 31, 2022 | $ |
Gross Carrying Amount | Accumulated Amortization | Intangible Assets, Net | |||||||||||||||
(in thousands) | |||||||||||||||||
Core/developed technology | $ | $ | $ | ||||||||||||||
Customer relationships | |||||||||||||||||
Contract rights intangible | |||||||||||||||||
Trademarks and trade names | |||||||||||||||||
Capitalized software development costs | |||||||||||||||||
Total | $ | $ | $ |
Gross Carrying Amount | Accumulated Amortization | Intangible Assets, Net | |||||||||||||||
(in thousands) | |||||||||||||||||
Core/developed technology | $ | $ | $ | ||||||||||||||
Customer relationships | |||||||||||||||||
Contract rights intangible | |||||||||||||||||
Trademarks and trade names | |||||||||||||||||
Capitalized software development costs | |||||||||||||||||
Total | $ | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Core/developed technology | $ | $ | |||||||||
Customer relationships | |||||||||||
Contract rights intangible | |||||||||||
Trademarks and trade names | |||||||||||
Capitalized software development costs(1) | |||||||||||
Total | $ | $ |
Fiscal year | (in thousands) | ||||
Remainder of fiscal 2022 | $ | ||||
2023 | |||||
2024 | |||||
2025 | |||||
2026 | |||||
2027 and thereafter | |||||
Total | $ |
As of | |||||||||||
January 31, 2022 | October 31, 2021 | ||||||||||
(in thousands) | |||||||||||
Other long-term assets: | |||||||||||
Deferred compensation plan assets | $ | $ | |||||||||
Capitalized commission, net | |||||||||||
Other long-term assets | |||||||||||
Total | $ | $ | |||||||||
Accounts payable and accrued liabilities: | |||||||||||
Payroll and related benefits | $ | $ | |||||||||
Other accrued liabilities | |||||||||||
Accounts payable | |||||||||||
Total | $ | $ | |||||||||
Other long-term liabilities: | |||||||||||
Deferred compensation plan liabilities | $ | $ | |||||||||
Other long-term liabilities | |||||||||||
Total | $ | $ |
Amortized Cost | Fair Value | ||||||||||
(in thousands) | |||||||||||
less than 1 year | $ | $ | |||||||||
1-5 years | |||||||||||
5-10 years | |||||||||||
>10 years | |||||||||||
Total | $ | $ |
Cost | Gross Unrealized Gains | Gross Unrealized Losses Less Than 12 Continuous Months | Gross Unrealized Losses 12 Continuous Months or Longer | Estimated Fair Value(1) | |||||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||
Money market funds | $ | $ | |||||||||||||||||||||||||||
Total: | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||
U.S. government agency & T-bills | $ | $ | ( | $ | |||||||||||||||||||||||||
Municipal bonds | ( | ||||||||||||||||||||||||||||
Corporate debt securities | ( | ||||||||||||||||||||||||||||
Asset-backed securities | ( | ||||||||||||||||||||||||||||
Total: | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||
Cost | Gross Unrealized Gains | Gross Unrealized Losses Less Than 12 Continuous Months | Gross Unrealized Losses 12 Continuous Months or Longer | Estimated Fair Value(1) | |||||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||
Money market funds | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Total: | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||
U.S. government agency & T-bills | $ | $ | $ | ( | $ | ||||||||||||||||||||||||
Municipal bonds | ( | ||||||||||||||||||||||||||||
Corporate debt securities | ( | ||||||||||||||||||||||||||||
Asset-backed securities | ( | ||||||||||||||||||||||||||||
Total: | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||
As of | |||||||||||
January 31, 2022 | October 31, 2021 | ||||||||||
(in thousands) | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash included in prepaid expenses and other current assets | |||||||||||
Restricted cash included in other long-term assets | |||||||||||
Total cash, cash equivalents and restricted cash | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Gain (loss) recorded in other income (expense), net | $ | $ |
As of | |||||||||||
January 31, 2022 | October 31, 2021 | ||||||||||
(in thousands) | |||||||||||
Total gross notional amount | $ | $ | |||||||||
Net fair value | $ | $ |
Fair values of derivative instruments designated as hedging instruments | Fair values of derivative instruments not designated as hedging instruments | ||||||||||
(in thousands) | |||||||||||
Balance at January 31, 2022 | |||||||||||
Other current assets | $ | $ | |||||||||
Accrued liabilities | $ | $ | |||||||||
Balance at October 31, 2021 | |||||||||||
Other current assets | $ | $ | |||||||||
Accrued liabilities | $ | $ |
Location of gain (loss) recognized in OCI on derivatives | Amount of gain (loss) recognized in OCI on derivatives (effective portion) | Location of gain (loss) reclassified from OCI | Amount of gain (loss) reclassified from OCI (effective portion) | ||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||
Three months ended January 31, 2022 | |||||||||||||||||||||||
Foreign exchange contracts | Revenue | $ | ( | Revenue | $ | ( | |||||||||||||||||
Foreign exchange contracts | Operating expenses | ( | Operating expenses | ( | |||||||||||||||||||
Total | $ | ( | $ | ( | |||||||||||||||||||
Three months ended January 31, 2021 | |||||||||||||||||||||||
Foreign exchange contracts | Revenue | $ | ( | Revenue | $ | ||||||||||||||||||
Foreign exchange contracts | Operating expenses | Operating expenses | |||||||||||||||||||||
Total | $ | $ | |||||||||||||||||||||
Fair Value Measurement Using | |||||||||||||||||||||||
Description | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
(in thousands) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||
Money market funds | $ | ||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||
U.S. government agency & T-bills | |||||||||||||||||||||||
Municipal bonds | |||||||||||||||||||||||
Corporate debt securities | |||||||||||||||||||||||
Asset-backed securities | |||||||||||||||||||||||
Prepaid and other current assets: | |||||||||||||||||||||||
Foreign currency derivative contracts | |||||||||||||||||||||||
Other long-term assets: | |||||||||||||||||||||||
Deferred compensation plan assets | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Accounts payable and accrued liabilities: | |||||||||||||||||||||||
Foreign currency derivative contracts | $ | $ | |||||||||||||||||||||
Other long-term liabilities: | |||||||||||||||||||||||
Deferred compensation plan liabilities | |||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ |
Fair Value Measurement Using | |||||||||||||||||||||||
Description | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
(in thousands) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||
Money market funds | $ | $ | |||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||
U.S. government agency & T-bills | |||||||||||||||||||||||
Municipal bonds | |||||||||||||||||||||||
Corporate debt securities | |||||||||||||||||||||||
Asset-backed securities | |||||||||||||||||||||||
Prepaid and other current assets: | |||||||||||||||||||||||
Foreign currency derivative contracts | |||||||||||||||||||||||
Other long-term assets: | |||||||||||||||||||||||
Deferred compensation plan assets | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Accounts payable and accrued liabilities: | |||||||||||||||||||||||
Foreign currency derivative contracts | $ | $ | |||||||||||||||||||||
Other long-term liabilities: | |||||||||||||||||||||||
Deferred compensation plan liabilities | |||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Operating lease expense (1) | $ | $ | |||||||||
Variable lease expense (2) | |||||||||||
Total lease expense | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Cash paid for amounts included in the measurement of operating lease liabilities | $ | $ | |||||||||
ROU assets obtained in exchange for operating lease liabilities | $ | $ |
As of | |||||||||||
January 31, 2022 | October 31, 2021 | ||||||||||
Weighted-average remaining lease term (in years) | |||||||||||
Weighted-average discount rate | % | % |
Lease Payments | |||||
Fiscal year | (in thousands) | ||||
Remainder of fiscal 2022 | $ | ||||
2023 | |||||
2024 | |||||
2025 | |||||
2026 | |||||
Thereafter | |||||
Total future minimum lease payments | |||||
Less: Imputed interest | |||||
Total lease liabilities | $ |
Lease Receipts | |||||
Fiscal year | (in thousands) | ||||
Remainder of fiscal 2022 | $ | ||||
2023 | |||||
2024 | |||||
2025 | |||||
2026 | |||||
Thereafter | |||||
Total | $ |
As of | |||||||||||
January 31, 2022 | October 31, 2021 | ||||||||||
(in thousands) | |||||||||||
Cumulative currency translation adjustments | $ | ( | $ | ( | |||||||
Unrealized gain (loss) on derivative instruments, net of taxes | ( | ( | |||||||||
Unrealized gain (loss) on available-for-sale securities, net of taxes | ( | ( | |||||||||
Total accumulated other comprehensive income (loss) | $ | ( | $ | ( |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Reclassifications from accumulated other comprehensive income (loss) into unaudited condensed consolidated statements of income: | |||||||||||
Gain (loss) on cash flow hedges, net of taxes | |||||||||||
Revenues | $ | ( | $ | ||||||||
Operating expenses | ( | ||||||||||
Total reclassifications into net income | $ | ( | $ |
Three Months Ended January 31, | |||||||||||
2022(2)(3) | 2021(1) | ||||||||||
(in thousands) | |||||||||||
Total shares repurchased | |||||||||||
Total cost of the repurchased shares | $ | $ | |||||||||
Reissuance of treasury stock |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Cost of products | $ | $ | |||||||||
Cost of maintenance and service | |||||||||||
Research and development expense | |||||||||||
Sales and marketing expense | |||||||||||
General and administrative expense | |||||||||||
Stock-based compensation expense before taxes | |||||||||||
Income tax benefit | ( | ( | |||||||||
Stock-based compensation expense after taxes | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Intrinsic value of awards exercised | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands, except per share amounts) | |||||||||||
Numerator: | |||||||||||
Net income attributed to Synopsys | $ | $ | |||||||||
Denominator: | |||||||||||
Weighted average common shares for basic net income per share | |||||||||||
Dilutive effect of common share equivalents | |||||||||||
Weighted average common shares for diluted net income per share | |||||||||||
Net income per share attributed to Synopsys: | |||||||||||
Basic | $ | $ | |||||||||
Diluted | $ | $ | |||||||||
Anti-dilutive employee stock-based awards excluded |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Total Segments: | |||||||||||
Revenue | $ | $ | |||||||||
Adjusted operating income | |||||||||||
Adjusted operating margin | % | % | |||||||||
Semiconductor & System Design: | |||||||||||
Revenue | $ | $ | |||||||||
Adjusted operating income | |||||||||||
Adjusted operating margin | % | % | |||||||||
Software Integrity: | |||||||||||
Revenue | $ | $ | |||||||||
Adjusted operating income | |||||||||||
Adjusted operating margin | % | % |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Total segment adjusted operating income | $ | $ | |||||||||
Reconciling items: | |||||||||||
Amortization of intangible assets | ( | ( | |||||||||
Stock-based compensation expense | ( | ( | |||||||||
Other | ( | ||||||||||
Total operating income | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Revenue: | |||||||||||
United States | $ | $ | |||||||||
Europe | |||||||||||
China | |||||||||||
Korea | |||||||||||
Other | |||||||||||
Consolidated | $ | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Interest income | $ | $ | |||||||||
Interest expense | ( | ( | |||||||||
Gain (loss) on assets related to deferred compensation plan | ( | ||||||||||
Foreign currency exchange gain (loss) | ( | ( | |||||||||
Other, net | ( | ||||||||||
Total | $ | ( | $ |
Three Months Ended January 31, | |||||||||||
2022 | 2021 | ||||||||||
(in thousands) | |||||||||||
Income before income taxes | $ | $ | |||||||||
Provision for income taxes | $ | $ | |||||||||
Effective tax rate | % | % |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||
Semiconductor & System Design Segment | $ | 1,162.7 | $ | 878.3 | $ | 284.4 | 32 | % | |||||||||||||||
Software Integrity Segment | 107.6 | 92.0 | 15.6 | 17 | % | ||||||||||||||||||
Total | $ | 1,270.3 | $ | 970.3 | $ | 300.0 | 31 | % | |||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | $ | 707.5 | $ | 631.3 | $ | 76.2 | 12 | % | |||||||||||||||
Percentage of total revenue | 56 | % | 65 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | $ | 368.3 | $ | 174.4 | $ | 193.9 | 111 | % | |||||||||||||||
Percentage of total revenue | 29 | % | 18 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||
Maintenance revenue | $ | 65.5 | $ | 54.2 | $ | 11.3 | 21 | % | |||||||||||||||
Professional services and other revenue | 129.0 | 110.5 | 18.5 | 17 | % | ||||||||||||||||||
Total | $ | 194.5 | $ | 164.7 | $ | 29.8 | 18 | % | |||||||||||||||
Percentage of total revenue | 15 | % | 17 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||
Cost of products revenue | $ | 165.4 | $ | 127.3 | $ | 38.1 | 30 | % | |||||||||||||||
Cost of maintenance and service revenue | 78.2 | 68.8 | 9.4 | 14 | % | ||||||||||||||||||
Amortization of intangible assets | 13.4 | 11.9 | 1.5 | 13 | % | ||||||||||||||||||
Total | $ | 257.0 | $ | 208.0 | $ | 49.0 | 24 | % | |||||||||||||||
Percentage of total revenue | 20 | % | 21 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | $ | 384.0 | $ | 357.5 | $ | 26.5 | 7 | % | |||||||||||||||
Percentage of total revenue | 30 | % | 37 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | $ | 180.5 | $ | 170.6 | $ | 9.9 | 6 | % | |||||||||||||||
Percentage of total revenue | 14 | % | 18 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | $ | 81.0 | $ | 77.5 | $ | 3.5 | 5 | % | |||||||||||||||
Percentage of total revenue | 6 | % | 8 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | 9.0 | 8.4 | 0.6 | 7 | % | ||||||||||||||||||
Percentage of total revenue | 1 | % | 1 | % | |||||||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | $ Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||
Interest income | $ | 0.9 | $ | 0.3 | $ | 0.6 | 200 | % | |||||||||||||||
Interest expense | (0.5) | (0.7) | 0.2 | (29) | % | ||||||||||||||||||
Gain (loss) on assets related to executive deferred compensation plan | (19.6) | 30.9 | (50.5) | (163) | % | ||||||||||||||||||
Foreign currency exchange gain (loss) | (1.0) | (0.3) | (0.7) | 233 | % | ||||||||||||||||||
Other, net | 0.4 | (1.4) | 1.8 | (129) | % | ||||||||||||||||||
Total | $ | (19.8) | $ | 28.8 | $ | (48.6) | (169) | % | |||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||
Adjusted operating income | $ | 447.4 | $ | 278.9 | $ | 168.5 | 60 | % | |||||||||||||||
Adjusted operating margin | 38 | % | 32 | % | 6 | % | 19 | % | |||||||||||||||
January 31, | |||||||||||||||||||||||
2022 | 2021 | Change | % Change | ||||||||||||||||||||
(dollars in millions) | |||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||
Adjusted operating income | $ | 12.0 | $ | 7.9 | $ | 4.1 | 52 | % | |||||||||||||||
Adjusted operating margin | 11 | % | 9 | % | 2 | % | 22 | % | |||||||||||||||
Three Months Ended January 31, | |||||||||||||||||
2022 | 2021 | $ Change | |||||||||||||||
(dollars in millions) | |||||||||||||||||
Cash provided by operating activities | $ | 155.7 | $ | 174.0 | $ | (18.3) | |||||||||||
Cash used in investing activities | (68.0) | (103.5) | 35.5 | ||||||||||||||
Cash used in financing activities | (394.6) | (293.1) | (101.5) |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Item 4. | Controls and Procedures |
Item 1. | Legal Proceedings |
Item 1A. | Risk Factors |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Period (1) | Total number of shares purchased (2) | Average price paid per share (2) | Total number of shares purchased as part of publicly announced programs | Maximum approximate dollar value of shares that may yet be purchased under the programs(1) | ||||||||||||||||||||||
Month #1 | ||||||||||||||||||||||||||
October 31, 2021 through November 4, 2021 | 107,701 | $ | 324.97 | 107,701 | $ | 110,001,339 | ||||||||||||||||||||
Month #2 | ||||||||||||||||||||||||||
November 5, 2021 through January 1, 2022 | 453,961 | $ | 360.89 | 442,845 | $ | 796,168,061 | ||||||||||||||||||||
Month #3 | ||||||||||||||||||||||||||
January 2, 2022 through January 29, 2022 | 139,773 | $ | 330.31 | — | $ | 750,000,270 | ||||||||||||||||||||
Total | 701,435 | $ | 349.28 | 550,546 | $ | 750,000,270 |
Item 6. | Exhibits |
Exhibit Number | Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||||||||||||||||
Exhibit Description | Form | File No. | Exhibit | Filing Date | ||||||||||||||||||||||||||||||||||
3.1 | 10-Q | 000-19807 | 3.1 | 9/15/2003 | ||||||||||||||||||||||||||||||||||
3.2 | 10-K | 000-19807 | 3.2 | 12/15/2020 | ||||||||||||||||||||||||||||||||||
4.1 | Specimen Common Stock Certificate | S-1 | 33-45138 | 4.3 | 2/24/1992 (effective date) | |||||||||||||||||||||||||||||||||
10.1 | 8-K | 000-19807 | 10.1 | 12/06/2021 | ||||||||||||||||||||||||||||||||||
10.2 | X | |||||||||||||||||||||||||||||||||||||
10.3 | X | |||||||||||||||||||||||||||||||||||||
31.1 | X | |||||||||||||||||||||||||||||||||||||
31.2 | X | |||||||||||||||||||||||||||||||||||||
31.3 | X | |||||||||||||||||||||||||||||||||||||
32.1 | X | |||||||||||||||||||||||||||||||||||||
101.INS | Inline XBRL Instance Document | X | ||||||||||||||||||||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
SYNOPSYS, INC. | ||||||||
Date: February 18, 2022 | By: | /s/ TRAC PHAM | ||||||
Trac Pham Chief Financial Officer (Principal Financial Officer) |
Participant: | %%FIRSTNAME%LASTNAME% | ||||
ID: | %%EMPLOYEE_IDENTIFIER%-% | ||||
Award Number: | %%OPTION_NUMBER%-% | ||||
Date of Grant: | %%OPTION_DATE%-% | ||||
Vesting Commencement Date: | %%VEST_BASE_DATE%-% | ||||
[TIME-BASED FORM: | |||||
Number of Restricted Stock Units: | %%TOTAL_SHARESGRANTED%] | ||||
[PERFORMANCE-BASED FORM: | |||||
Target Number of PRSUs: | %%TOTAL_SHARES_GRANTED%-% | ||||
Maximum Number of PRSUs: | %%TOTAL_SHARES_GRANTED%-%] | ||||
Payment for Common Stock: | Participant’s future services |
By signing this Notice and Agreement below or, in case this information is presented to you electronically, by clicking the “Accept” or similar button implemented into the relevant web page or platform, you declare, without limitation, your consent to the data processing operations described in this Notice and Agreement. You may withdraw your consent at any time with future effect for any or no reason as described in Section 12(e) above. |
Synopsys, Inc. | Participant | ||||
By: ____________________________ | By: ____________________________ | ||||
Title: ___________________________ | Name: __________________________ | ||||
Date: ___________________________ | Date: ___________________________ |
2006 Employee Equity Incentive Plan Notice of Grant of Stock Options and Option Agreement | Synopsys, Inc. ID: 56-1546236 690 East Middlefield Road Mountain View, CA 94043 | ||||
%%FIRST_NAME%-%LAST_NAME%-% %%ADDRESS_LINE_1%-% %%ADDRESS_LINE_2%-% %%CITY%-%STATE%-%ZIPCODE%-% %%COUNTRY%-% | Option Number: %%OPTION_NUMBER%-% ID: %%EMPLOYEE_IDENTIFIER%-% |
By signing this Notice and Agreement below or, in case this information is presented to you electronically, by clicking the “Accept” or similar button implemented into the relevant web page or platform, you declare, without limitation, your consent to the data processing operations described in this Notice and Agreement. You may withdraw your consent at any time with future effect for any or no reason as described in Section 12(e) above. |
SYNOPSYS, INC. | PARTICIPANT | ||||
By: ____________________________ | By: ____________________________ | ||||
Title: ___________________________ | Name: __________________________ | ||||
Date: ___________________________ | Date: ___________________________ |
Date: February 18, 2022 | /s/ Aart J. de Geus | |||||||
Aart J. de Geus Co-Chief Executive Officer and Chairman (Co-Principal Executive Officer) |
Date: February 18, 2022 | /s/ Chi-Foon Chan | |||||||
Chi-Foon Chan Co-Chief Executive Officer (Co-Principal Executive Officer) |
Date: February 18, 2022 | /s/ Trac Pham | |||||||
Trac Pham Chief Financial Officer (Principal Financial Officer) |
/s/ Aart J. de Geus | |||||
Aart J. de Geus Co-Chief Executive Officer and Chairman | |||||
/s/ Chi-Foon Chan | |||||
Chi-Foon Chan Co-Chief Executive Officer | |||||
/s/ Trac Pham | |||||
Trac Pham Chief Financial Officer |
:C4/+>DV?=:\>T"J51G;:'87],K-.K
ML-6(9+),-Z-LI3Y*,AFT 9+5+:/L)9P(RWZU.:3Q&
M)O>LMCIC(G$($'B
Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Preferred Stock, par value (in USD per share) | $ 0.01 | $ 0.01 |
Preferred Stock, shares authorized (in shares) | 2,000,000 | 2,000,000 |
Preferred Stock, shares outstanding (in shares) | 0 | 0 |
Common Stock, par value (in USD per share) | $ 0.01 | $ 0.01 |
Common Stock, shares authorized (in shares) | 400,000,000 | 400,000,000 |
Common Stock, shares outstanding (in shares) | 153,256,000 | 153,062,000 |
Treasury stock, shares (in shares) | 4,005,000 | 4,198,000 |
Unaudited Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 313,341 | $ 162,028 |
Other comprehensive income (loss): | ||
Change in foreign currency translation adjustment | (613) | 17,932 |
Changes in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented | (500) | 0 |
Cash flow hedges: | ||
Deferred gains (losses), net of tax $230 and $(1,405), respectively. | (1,585) | 4,093 |
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $(302) and $885, respectively. | 845 | (2,726) |
Other comprehensive income (loss), net of tax effects | (1,853) | 19,299 |
Comprehensive income | 311,488 | 181,327 |
Less: net income (loss) attributed to non-controlling interest | (346) | (317) |
Comprehensive income attributed to Synopsys | $ 311,834 | $ 181,644 |
Unaudited Condensed Consolidated Statements Of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||
Deferred gain (loss), tax | $ 230 | $ (1,405) |
Reclassification adjustment on deferred (gains) loss included in net income, tax | $ (302) | $ 885 |
Unaudited Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($) shares in Thousands, $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjustment [Member] |
Common Stock |
Capital in Excess of Par Value |
Retained Earnings |
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment [Member]
|
Treasury Stock |
Accumulated Other Comprehensive Income (Loss) |
Total Synopsys Stockholders’ Equity |
Non-controlling Interest |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance (in shares) at Oct. 31, 2020 | 152,618 | ||||||||||||||||||
Beginning balance at Oct. 31, 2020 | $ 4,912,367 | $ 1,528 | $ 1,653,166 | $ 3,795,397 | $ (488,613) | $ (54,074) | $ 4,907,404 | $ 4,963 | |||||||||||
Beginning balance (Retained earnings adjustment due to adoption of ASC 326) at Oct. 31, 2020 | [1] | $ (3,200) | $ (3,200) | ||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
Net income | 162,028 | 162,345 | 162,345 | (317) | |||||||||||||||
Other comprehensive income (loss), net of tax effects | $ 19,299 | 19,299 | 19,299 | ||||||||||||||||
Purchases of treasury stock (in shares) | (837) | [2] | (837) | ||||||||||||||||
Purchases of treasury stock | $ (202,871) | [2] | $ (8) | 8 | (202,871) | (202,871) | |||||||||||||
Equity forward contract, net | $ (50,000) | (50,000) | (50,000) | ||||||||||||||||
Common stock issued, net of shares withheld for employee taxes (in shares) | 583 | [2] | 583 | ||||||||||||||||
Common stock issued, net of shares withheld for employee taxes | $ (34,507) | $ 6 | (97,781) | 63,268 | (34,507) | ||||||||||||||
Stock-based compensation | 83,782 | 83,782 | 83,782 | ||||||||||||||||
Balance (in shares) at Jan. 31, 2021 | 152,364 | ||||||||||||||||||
Ending balance at Jan. 31, 2021 | 4,886,898 | $ 1,526 | 1,589,175 | 3,954,542 | (628,216) | (34,775) | 4,882,252 | 4,646 | |||||||||||
Balance (in shares) at Oct. 31, 2021 | 153,062 | ||||||||||||||||||
Beginning balance at Oct. 31, 2021 | 5,298,943 | $ 1,531 | 1,576,363 | 4,549,713 | (782,866) | (49,604) | 5,295,137 | 3,806 | |||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||
Net income | 313,341 | 313,687 | 313,687 | (346) | |||||||||||||||
Other comprehensive income (loss), net of tax effects | $ (1,853) | (1,853) | (1,853) | ||||||||||||||||
Purchases of treasury stock (in shares) | (701) | [3],[4] | (701) | ||||||||||||||||
Purchases of treasury stock | $ (245,000) | [3],[4] | $ (7) | 7 | (245,000) | (245,000) | |||||||||||||
Equity forward contract, net | $ (5,000) | (5,000) | (5,000) | ||||||||||||||||
Common stock issued, net of shares withheld for employee taxes (in shares) | 895 | [3],[4] | 895 | ||||||||||||||||
Common stock issued, net of shares withheld for employee taxes | $ (65,969) | $ 9 | (236,915) | 170,937 | (65,969) | ||||||||||||||
Stock-based compensation | 95,771 | 95,771 | 95,771 | ||||||||||||||||
Balance (in shares) at Jan. 31, 2022 | 153,256 | ||||||||||||||||||
Ending balance at Jan. 31, 2022 | $ 5,390,233 | $ 1,533 | $ 1,430,226 | $ 4,863,400 | $ (856,929) | $ (51,457) | $ 5,386,773 | $ 3,460 | |||||||||||
|
Description of Business |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Accounting Policies [Abstract] | |
Description of Business | Description of Business Synopsys, Inc. (we, our or us) provides products and services used across the entire silicon to software spectrum, from engineers creating advanced semiconductors to software developers seeking to ensure the security and quality of their code. We are a global leader in supplying the electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs), also known as chips. We also offer semiconductor intellectual property (IP) products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves. We provide software and hardware used to validate the electronic systems that incorporate chips and the software that runs on them. To complement these offerings, we provide technical services and support to help our customers develop advanced chips and electronic systems. These products and services are part of our Semiconductor & System Design segment. We are also a leading provider of software tools and services that improve the security, quality and compliance of software in a wide variety of industries, including electronics, financial services, automotive, medicine, energy and industrials. These tools and services are part of our Software Integrity segment.
|
Summary of Significant Accounting Policies |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies We have prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Pursuant to these rules and regulations, we have condensed or omitted certain information and footnote disclosures we normally include in our annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). In management’s opinion, we have made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary to fairly present our unaudited condensed consolidated balance sheets, results of operations, comprehensive income, stockholders’ equity and cash flows. Our interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended October 31, 2021 as filed with the SEC on December 13, 2021. Use of Estimates. To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on our operating results and financial position. Principles of Consolidation. The unaudited condensed consolidated financial statements include our accounts and the accounts of our subsidiaries. All intercompany accounts and transactions have been eliminated. Fiscal Year End. Our fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, we have a 53-week year. When a 53-week year occurs, we include the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2022 and 2021 are both 52-week years. Fiscal 2022 will end on October 29, 2022. Fiscal 2021 ended on October 30, 2021. For presentation purposes, the unaudited condensed consolidated financial statements and accompanying notes refer to the closest calendar month end. Significant Accounting Policies. There have been no material changes to our significant accounting policies summarized in Note 2. Summary of Significant Accounting Policies to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended October 31, 2021. Recently Adopted Accounting Pronouncements In December 2019, FASB issued Accounting Standards Update (ASU) 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. We adopted the standard as of the beginning of fiscal 2022 on a prospective basis and the adoption of this standard did not have a material impact on our unaudited condensed consolidated financial statements. Recent Accounting Pronouncements Not Yet Adopted In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date. The new standard is effective for our fiscal year beginning on November 1, 2023. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our unaudited condensed consolidated financial statements.
|
Revenue |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue | Revenue Disaggregated Revenue The following table showed the percentage of revenue by product groups:
Contract Balances The contract assets indicated below are presented as prepaid and other current assets in the unaudited condensed consolidated balance sheets. The contract assets are transferred to receivables when the rights to invoice and receive payment become unconditional. Unbilled receivables are presented as accounts receivable, net, in the unaudited condensed consolidated balance sheets. Contract balances were as follows:
During the three months ended January 31, 2022, we recognized revenue of $609.5 million that was included in the deferred revenue balance as of October 31, 2021. Contracted but unsatisfied or partially unsatisfied performance obligations were approximately $6.9 billion as of January 31, 2022, which includes $866.9 million in non-cancellable Flexible Spending Account (FSA) commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date. We have elected to exclude future sales-based royalty payments from the remaining performance obligations. Approximately 41% of the contracted but unsatisfied or partially unsatisfied performance obligations as of January 31, 2022, excluding non-cancellable FSA, are expected to be recognized over the next 12 months, with the remainder recognized thereafter. During the three months ended January 31, 2022 and 2021, we recognized $32.0 million and $26.3 million, respectively, from performance obligations satisfied from sales-based royalties earned during the periods. Costs of Obtaining a Contract with Customer Capitalized commission costs, net of accumulated amortization, as of January 31, 2022 were $96.8 million and included in other long-term assets in our unaudited condensed consolidated balance sheets. Amortization of these assets was $16.7 million and $15.0 million during the three months ended January 31, 2022 and 2021, respectively, and included in sales and marketing expense in our unaudited condensed consolidated statements of income.
|
Business Combinations |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Business Combinations [Abstract] | |
Business Combinations | Business Combinations During the three months ended January 31, 2022, we completed one acquisition for an aggregate consideration of $20.0 million, net of cash acquired. We do not consider this acquisition to be material to our unaudited condensed consolidated statements of income. The preliminary purchase allocations are $4.3 million of identifiable intangible assets and $15.7 million in goodwill, which are attributable to the Semiconductor & System Design reporting segment. There was no tax deductible goodwill related to the acquisition. The preliminary fair value estimates for the assets acquired and liabilities assumed for all acquisitions completed within 12 months from the applicable acquisition date are not yet finalized and may change as additional information becomes available during the respective measurement periods. The primary areas of those preliminary estimates relate to certain tangible assets and liabilities, identifiable intangible assets, and income taxes. Acquisition-Related Transaction Costs Transaction costs were $2.1 million and $3.5 million during the three months ended January 31, 2022 and January 31, 2021, respectively. These costs mainly consist of professional fees and administrative costs and were expensed as incurred in our unaudited condensed consolidated statements of income.
|
Goodwill and Intangible Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill The changes in the carrying amount of goodwill during the three months ended January 31, 2022 were as follows:
During the three months ended January 31, 2022, we finalized certain estimates impacting total purchase consideration for certain acquisitions and recorded the resulting measurement period adjustments which increased goodwill. Intangible Assets Intangible assets as of January 31, 2022 consisted of the following:
Intangible assets as of October 31, 2021 consisted of the following:
Amortization expense related to intangible assets consisted of the following:
(1) Amortization of capitalized software development costs is included in cost of products revenue in the unaudited condensed consolidated statements of income. The following table presented the estimated future amortization of intangible assets as of January 31, 2022:
|
Balance Sheets Components |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheets Components | Balance Sheets Components
|
Financial Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Assets And Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Assets and Liabilities | Financial Assets and Liabilities Short-term investments. Gross unrealized gains and losses on our available-for-sale debt securities as of January 31, 2022 were not significant. The stated maturities of our available-for-sale debt securities as of January 31, 2022 were as follows:
As of January 31, 2022, the balances of our cash equivalents and short-term investments were as follows:
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments. As of October 31, 2021, the balances of our cash equivalents and short-term investments were as follows:
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments. Restricted cash. We include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the unaudited condensed consolidated statements of cash flows. All restricted cash is primarily associated with office leases. The following table provided a reconciliation of cash, cash equivalents and restricted cash included in the unaudited condensed consolidated balance sheets:
Non-marketable equity securities. Our portfolio of non-marketable equity securities consists of strategic investments in privately held companies. There were no impairments of non-marketable equity securities during the three months ended January 31, 2022 and January 31, 2021. Derivatives We recognize derivative instruments as either assets or liabilities in the unaudited condensed consolidated balance sheets at fair value and provide qualitative and quantitative disclosures about such derivatives. We operate internationally and are exposed to potentially adverse movements in foreign currency exchange rates. We enter into hedges in the form of foreign currency forward contracts to reduce our exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions including: (1) certain assets and liabilities, (2) shipments forecasted to occur within approximately one month, (3) future billings and revenue on previously shipped orders, and (4) certain future intercompany invoices denominated in foreign currencies. The duration of forward contracts ranges from approximately one month to 24 months, the majority of which are short-term. We do not use foreign currency forward contracts for speculative or trading purposes. We enter into foreign exchange forward contracts with high credit quality financial institutions that are rated ‘A’ or above and to date have not experienced nonperformance by counterparties. In addition, we mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty and anticipate continued performance by all counterparties to such agreements. The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the unaudited condensed consolidated balance sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and qualifies for hedge accounting. The cash flow impact upon settlement of the derivative contracts will be included in net cash provided by operating activities in the unaudited condensed consolidated statements of cash flows. Cash Flow Hedging Activities Certain foreign exchange forward contracts are designated and qualify as cash flow hedges. These contracts have durations of approximately 24 months or less. Certain forward contracts are rolled over periodically to capture the full length of exposure to our foreign currency risk, which can be up to three years. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. The related gains or losses resulting from changes in fair value of these hedges is initially reported, net of tax, as a component of other comprehensive income (loss) (OCI) in stockholders’ equity and reclassified into revenue or operating expenses, as appropriate, at the time the hedged transactions affect earnings. We expect a majority of the hedge balance in OCI to be reclassified to the statements of income within the next 12 months. We did not record any gains or losses related to discontinuation of cash flow hedges during the three months ended January 31, 2022 and 2021. Non-designated Hedging Activities Our foreign exchange forward contracts that are used to hedge non-functional currency denominated balance sheet assets and liabilities are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the underlying assets and liabilities, which are also recorded in other income (expense), net. The duration of the forward contracts for hedging our balance sheet exposure is approximately one month. We also have certain foreign exchange forward contracts for hedging certain international revenues and expenses that are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the foreign currency in operating income. The duration of these forward contracts is usually less than one year. The overall goal of our hedging program is to minimize the impact of currency fluctuations on the net income over the fiscal year. The effects of the non-designated derivative instruments on our unaudited condensed consolidated statements of income were summarized as follows:
The notional amounts in the table below for derivative instruments provided one measure of the transaction volume outstanding:
Our exposure to market gain or loss will vary over time as a function of currency exchange rates. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. The following table represented the unaudited condensed consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
The following table represented the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the unaudited condensed consolidated statements of income:
|
Fair Value Measures |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measures | Fair Value Measurements ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements. The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement: Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets; Level 2—Observable inputs other than quoted prices included in Level 1 for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3—Unobservable inputs to the valuation derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable. On a recurring basis, we measure the fair value of certain of our assets and liabilities, which include cash equivalents, non-qualified deferred compensation plan assets, and foreign currency derivative contracts. Our cash equivalents and short-term investments are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs. Our non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1. Our foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded, and the valuation inputs are based on quoted prices and market observable data of similar instruments. Our borrowings under the credit and term loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available for our debt with similar terms and maturities. See Note 10. Credit and Term Loan Facilities for more information on these borrowings. Assets/Liabilities Measured at Fair Value on a Recurring Basis Assets and liabilities measured at fair value on a recurring basis were summarized below as of January 31, 2022:
Assets and liabilities measured at fair value on a recurring basis were summarized below as of October 31, 2021:
Assets/Liabilities Measured at Fair Value on a Non-Recurring Basis Non-Marketable Equity Securities Non-marketable equity securities are classified within Level 3 as they are valued using significant unobservable inputs or data in an inactive market due to the absence of market price and inherent lack of liquidity.
|
Restructuring Charges |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Payables and Accruals [Abstract] | |
Restructuring Charges | Restructuring Charges In the third quarter of fiscal 2021, we initiated a restructuring plan for involuntary and voluntary employee termination and facility closure actions as part of a business reorganization (the 2021 Plan). During the first quarter of fiscal 2022, we recorded restructuring charges of $11.7 million consisting primarily of severance, retirement benefits under the 2021 Voluntary Retirement Program (2021 VRP) and lease abandonment costs, and made payments of $4.9 million under the 2021 Plan. The 2021 Plan and VRP were completed in the first quarter of fiscal 2022 and the total charges under the 2021 Plan were $45.2 million. As of January 31, 2022, $21.0 million of restructuring related liabilities remained outstanding and was recorded in accounts payable and accrued liabilities in the unaudited condensed consolidated balance sheets.
|
Credit and Term Loan Facilities |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Debt Disclosure [Abstract] | |
Credit and Term Loan Facilities | Credit and Term Loan Facilities On January 22, 2021, we entered into a Fourth Extension and Amendment Agreement (the Fourth Amendment), which amended and restated our previous credit agreement, dated as of November 28, 2016 (as amended and restated, the Credit Agreement). Our outstanding borrowings under the previous credit agreement, which as of January 22, 2021 consisted of term loans in the aggregate principal amount of $97.5 million, were carried over under the Credit Agreement. As of January 31, 2022, there was no balance outstanding under the term loans. The Fourth Amendment extended the termination date of the existing $650.0 million senior unsecured revolving credit facility from November 28, 2021 to January 22, 2024, which could be further extended at our option. The Credit Agreement also provides an uncommitted incremental loan facility of up to $150 million in the aggregate principal amount. The Credit Agreement contains financial covenants requiring us to maintain a maximum consolidated leverage ratio and a minimum consolidated interest coverage ratio, as well as other non-financial covenants. As of January 31, 2022, we were in compliance with all financial covenants. There was no outstanding balance under the Revolver as of January 31, 2022 and October 31, 2021. We expect our borrowings under the Revolver will fluctuate from quarter to quarter. Borrowings bear interest at a floating rate based on a margin over our choice of market observable base rates as defined in the Credit Agreement. As of January 31, 2022, Revolver bore interest at LIBOR +1.000%. In addition, commitment fees are payable on the Revolver at rates between 0.125% and 0.200% per year based on our leverage ratio on the daily amount of the revolving commitment. In July 2018, we entered into a 12-year 220.0 million RMB (approximately $33.0 million) credit agreement with a lender in China to support our facilities expansion. Borrowings bear interest at a floating rate based on the 5 year Loan Prime Rate plus 0.74%. As of January 31, 2022, we had $24.3 million outstanding under the agreement. The carrying amount of the short-term and long-term debt approximates the estimated fair value. These borrowings under the Credit Agreement have a variable interest rate structure and are classified within Level 2 of the fair value hierarchy.
|
Leases |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases | Leases We have operating lease arrangements for office space, data center, equipment and other corporate assets. These leases have various expiration dates through December 31, 2040, some of which include options to extend the leases for up to 10 years. Because we are not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term and associated potential option payments are excluded from lease payments. The components of our lease expense during the period presented were as follows:
(1) Operating lease expense includes immaterial amounts of short-term leases, net of sublease income. (2) Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments. Supplemental cash flow information during the period presented was as follows:
Lease term and discount rate information related to our operating leases as of the end of the period presented were as follows:
The following represented the maturities of our future lease payments due under operating leases as of January 31, 2022:
In addition, certain facilities owned by us were leased to third parties under non-cancellable operating lease agreements. These leases have annual escalating payments and have expiration dates through March 31, 2031 in accordance with the terms and conditions of the existing agreement. The lease receipts from owned facilities, including sublease income from other facilities, due to us as of January 31, 2022 were as follows:
|
Accumulated Other Comprehensive Income (Loss) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) Components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income was as follows:
|
Stock Repurchase Program |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Repurchase Program [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Repurchase Program | Stock Repurchase Program Our Board of Directors (the Board) approved a stock repurchase program with authorization to purchase up to $1.0 billion of our common stock in December 2021. As of January 31, 2022, $750.0 million remained available for future repurchases under the program. In December 2021, we entered into an accelerated share repurchase agreement (the December 2021 ASR) to repurchase an aggregate of $200.0 million of our common stock. Pursuant to the December 2021 ASR, we made a prepayment of $200.0 million to receive initial deliveries of shares valued at $160.0 million. The remaining balance of $40.0 million was settled in February 2022. Total shares purchased under the December 2021 ASR were approximately 0.6 million shares, at an average purchase price of $331.09 per share. During the three months ended January 31, 2022, we also repurchased on the open market approximately 0.2 million shares of our common stock at an average price of $331.37 per share for an aggregate purchase price of $50.0 million. Stock repurchase activities as well as the reissuance of treasury stock for employee stock-based compensation purposes were as follows:
(1) Excluded the 166,726 shares and $50.0 million equity forward contract from the December 2020 ASR settled in March 2021. (2) Included 107,701 shares and $35.0 million equity forward contract from the August 2021 ASR settled in November 2021. (3) Excluded the 161,215 shares and $40.0 million equity forward contract from the December 2021 ASR settled in February 2022.
|
Stock-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation | Stock-Based Compensation The compensation cost recognized in the unaudited condensed consolidated statements of income for our stock compensation arrangements was as follows:
As of January 31, 2022, we had $945.9 million of total unrecognized stock-based compensation expense relating to options, restricted stock units and restricted stock awards, which is expected to be recognized over a weighted-average period of 2.5 years. As of January 31, 2022, we had $35.9 million of unrecognized stock-based compensation expense relating to our Employee Stock Purchase Plan (ESPP), which is expected to be recognized over a period of approximately 2.0 years. The intrinsic values of equity awards exercised during the periods were as follows:
|
Net Income per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income per Share | Net Income Per ShareWe compute basic net income per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income per share reflects the dilution from potential common shares outstanding such as stock options and unvested restricted stock units and awards during the period using the treasury stock method. The table below reconciled the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
|
Segment Disclosure |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Disclosure | Segment Disclosure Segment reporting is based upon the “management approach,” i.e., how management organizes our operating segments for which separate financial information is (1) available and (2) evaluated regularly by the Chief Operating Decision Makers (CODMs) in deciding how to allocate resources and in assessing performance. The CODMs are our two Co-Chief Executive Officers. We have two reportable segments: (1) Semiconductor & System Design, which includes EDA tools, IP products, system integration solutions and other associated revenue categories, and (2) Software Integrity, which includes a comprehensive solution for building integrity—security, quality and compliance testing—into the customers’ software development lifecycle and supply chain. The financial information provided to and used by the CODMs to assist in making operational decisions, allocating resources, and assessing performance reflects consolidated financial information as well as revenue, adjusted operating income, and adjusted operating margin information for the Semiconductor & System Design and Software Integrity segments, accompanied by disaggregated information relating to revenue by geographic region. Information by reportable segment was as follows:
Certain operating expenses are not allocated to the segments and are managed at a consolidated level. The unallocated expenses managed at a consolidated level, including amortization of intangible assets, stock-based compensation and certain other operating expenses, were presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
The CODMs do not use total assets by segment to evaluate segment performance or allocate resources. As a result, total assets by segment are not required to be disclosed. In allocating revenue to particular geographic areas, the CODMs consider where individual “seats” or licenses to our products are located. Revenue is defined as revenue from external customers. Revenue related to operations in the United States and other geographic areas were:
Geographic revenue data for multi-regional, multi-product transactions reflect internal allocations and are therefore subject to certain assumptions and to our methodology.
|
Other Income (Expense), Net |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expenses [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income (Expense), Net | Other Income (Expense), Net The following table presented the components of other income (expense), net:
|
Income Taxes |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes | Income Taxes Effective Tax Rate We estimate our annual effective tax rate at the end of each fiscal quarter. The effective tax rate takes into account our estimations of annual pre-tax income, the geographic mix of pre-tax income and interpretations of tax laws and possible outcomes of audits. The following table presented the provision for income taxes and the effective tax rates:
Our effective tax rate for the three months ended January 31, 2022 is lower than the statutory federal corporate tax rate of 21.0% primarily due to U.S. federal research tax credits, foreign-derived intangible income deduction, excess tax benefits from stock-based compensation, and U.S. foreign tax credits, partially offset by state taxes, the effect of non-deductible stock-based compensation, and higher taxes on certain foreign earnings. Our effective tax rate decreased in the three months ended January 31, 2022 as compared to the same period in fiscal 2021, primarily due to excess tax benefits from stock-based compensation. The timing of the resolution of income tax examinations, and the amounts and timing of various tax payments that are part of the settlement process, are highly uncertain. Variations in such amounts and/or timing could cause large fluctuations in the balance sheet classification of current and non-current assets and liabilities. We believe that in the coming 12 months, it is reasonably possible that either certain audits and ongoing tax litigation will conclude or the statute of limitations on certain state and foreign income and withholding taxes will expire, or both. Given the uncertainty as to ultimate settlement terms, the timing of payment and the impact of such settlements on other uncertain tax positions, the range of the estimated potential decrease in underlying unrecognized tax benefits is between $0 and $45 million. Non-U.S. Examinations Hungarian Tax Authority In 2017, the Hungarian Tax Authority (the HTA) assessed withholding taxes of approximately $25.0 million and interest and penalties of $11.0 million, against our Hungary subsidiary (Synopsys Hungary). Synopsys Hungary contested the assessment with the Hungarian Administrative Court (Administrative Court). As required under Hungarian law, Synopsys Hungary paid the assessment and recorded a tax expense due to an unrecognized tax benefit of $17.4 million, which is net of estimated U.S. foreign tax credits. The Administrative Court found against Synopsys Hungary, and we appealed to the Hungarian Supreme Court. During 2021, the Hungarian Supreme Court heard our appeal and remanded the case to the Administrative Court for further proceedings. The Administrative Court once again ruled against Synopsys Hungary and we filed another appeal with the Hungarian Supreme Court. The Hungarian Supreme Court heard our appeal on January 27, 2022, vacated the lower court's decision and remanded the case back to the Administrative Court for further proceedings. We expect to receive the Hungarian Supreme Court's written decision in the second quarter of fiscal 2022. We are also under examination by the tax authorities in certain other jurisdictions. No material assessments have been proposed in these examinations.
|
Contingencies |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | Contingencies Legal Proceedings We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate outcome of any litigation is often uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. We regularly review the status of each significant matter and assesses our potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and, as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated. We have determined that, except as set forth below, no disclosure of estimated loss is required for a claim against us because: (1) there is not a reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim; (2) a reasonably possible loss or range of loss cannot be estimated; or (3) such estimate is immaterial. Legal Settlement There have been no changes to the disclosure related to Mentor Graphics Corporation (now part of Siemens AG) since our Annual Report on Form 10-K for the fiscal year ended October 31, 2021. See Note 9. Contingencies of the Annual Report for further information. Tax Matters We undergo examination from time to time by U.S. and foreign authorities for non-income based taxes, such as sales, use and value-added taxes, and are currently under examination by tax authorities in certain jurisdictions. If the potential loss from such examinations is considered probable and the amount or the range of loss could be estimated, we would accrue a liability for the estimated expense. In addition to the foregoing, we are, from time to time, party to various other claims and legal proceedings in the ordinary course of our business, including with tax and other governmental authorities. For a description of certain of these other matters, see Note 18. Income Taxes.
|
Summary of Significant Accounting Policies (Policies) |
3 Months Ended |
---|---|
Jan. 31, 2022 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates. To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on our operating results and financial position. |
Principles of Consolidation | Principles of Consolidation. The unaudited condensed consolidated financial statements include our accounts and the accounts of our subsidiaries. All intercompany accounts and transactions have been eliminated. |
Fiscal Year End | Fiscal Year End. Our fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, we have a 53-week year. When a 53-week year occurs, we include the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2022 and 2021 are both 52-week years. Fiscal 2022 will end on October 29, 2022. Fiscal 2021 ended on October 30, 2021. For presentation purposes, the unaudited condensed consolidated financial statements and accompanying notes refer to the closest calendar month end. |
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted | Recently Adopted Accounting Pronouncements In December 2019, FASB issued Accounting Standards Update (ASU) 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. We adopted the standard as of the beginning of fiscal 2022 on a prospective basis and the adoption of this standard did not have a material impact on our unaudited condensed consolidated financial statements. Recent Accounting Pronouncements Not Yet Adopted In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date. The new standard is effective for our fiscal year beginning on November 1, 2023. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our unaudited condensed consolidated financial statements.
|
Revenue (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Disaggregation of Revenue | The following table showed the percentage of revenue by product groups:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Contract Assets and Liabilities | Contract balances were as follows:
|
Goodwill and Intangible Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill | The changes in the carrying amount of goodwill during the three months ended January 31, 2022 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Intangible Assets | Intangible assets as of January 31, 2022 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amortization Expense Related to Intangible Assets | Amortization expense related to intangible assets consisted of the following:
(1) Amortization of capitalized software development costs is included in cost of products revenue in the unaudited condensed consolidated statements of income.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Estimated Future Amortization of Intangible Assets | The following table presented the estimated future amortization of intangible assets as of January 31, 2022:
|
Balance Sheets Components (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Balance Sheets Components |
|
Financial Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Assets And Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Available-for-sale | The stated maturities of our available-for-sale debt securities as of January 31, 2022 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Cash Equivalents | As of January 31, 2022, the balances of our cash equivalents and short-term investments were as follows:
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments. As of October 31, 2021, the balances of our cash equivalents and short-term investments were as follows:
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash, Cash Equivalents and Restricted Cash | The following table provided a reconciliation of cash, cash equivalents and restricted cash included in the unaudited condensed consolidated balance sheets:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effects on Changes in Fair Values of Non-Designated Forward Contracts | The effects of the non-designated derivative instruments on our unaudited condensed consolidated statements of income were summarized as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notional Amounts of Derivative Instruments | The notional amounts in the table below for derivative instruments provided one measure of the transaction volume outstanding:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet | The following table represented the unaudited condensed consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Statement Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax |
|
Fair Value Measures (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and Liabilities Measured at Fair Value on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis were summarized below as of January 31, 2022:
|
Leases (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lease, Cost | The components of our lease expense during the period presented were as follows:
(1) Operating lease expense includes immaterial amounts of short-term leases, net of sublease income. (2) Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments. Supplemental cash flow information during the period presented was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee, Lease Term and Discount Rate | Lease term and discount rate information related to our operating leases as of the end of the period presented were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee, Operating Lease, Liability, Maturity | The following represented the maturities of our future lease payments due under operating leases as of January 31, 2022:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity | The lease receipts from owned facilities, including sublease income from other facilities, due to us as of January 31, 2022 were as follows:
|
Accumulated Other Comprehensive Income (Loss) (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Accumulated Other Comprehensive Income (Loss) | Components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income | The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income was as follows:
|
Stock Repurchase Program (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Repurchase Program [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Repurchase And Reissuance Activities | Stock repurchase activities as well as the reissuance of treasury stock for employee stock-based compensation purposes were as follows:
(1) Excluded the 166,726 shares and $50.0 million equity forward contract from the December 2020 ASR settled in March 2021. (2) Included 107,701 shares and $35.0 million equity forward contract from the August 2021 ASR settled in November 2021. (3) Excluded the 161,215 shares and $40.0 million equity forward contract from the December 2021 ASR settled in February 2022.
|
Stock-Based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Compensation Arrangements | The compensation cost recognized in the unaudited condensed consolidated statements of income for our stock compensation arrangements was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intrinsic Value of Equity Awards Exercised | The intrinsic values of equity awards exercised during the periods were as follows:
|
Net Income per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Weighted-Average Common Shares Used to Calculate Net Income Per Share | The table below reconciled the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
|
Segment Disclosure (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information | Information by reportable segment was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Operating Income From Segment Consolidation | The unallocated expenses managed at a consolidated level, including amortization of intangible assets, stock-based compensation and certain other operating expenses, were presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues Related to Operations by Geographic Areas | Revenue related to operations in the United States and other geographic areas were:
|
Other Income (Expense), Net (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expenses [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Other Income (Expense), Net | The following table presented the components of other income (expense), net:
|
Income Taxes (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Provision (Benefit) for Incomes Taxes and Effective Tax Rates | The following table presented the provision for income taxes and the effective tax rates:
|
Revenue - Schedule of Disaggregation of Revenue (Details) - Product Concentration Risk - Revenue |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Disaggregation of Revenue [Line Items] | ||
Revenue percentage by product group | 100.00% | 100.00% |
EDA | ||
Disaggregation of Revenue [Line Items] | ||
Revenue percentage by product group | 49.80% | 55.20% |
IP & System Integration | ||
Disaggregation of Revenue [Line Items] | ||
Revenue percentage by product group | 41.50% | 35.00% |
Software Integrity Products & Services | ||
Disaggregation of Revenue [Line Items] | ||
Revenue percentage by product group | 8.50% | 9.50% |
Other | ||
Disaggregation of Revenue [Line Items] | ||
Revenue percentage by product group | 0.20% | 0.30% |
Revenue - Schedule of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Revenue from Contract with Customer [Abstract] | ||
Contract assets | $ 274,009 | $ 284,574 |
Unbilled receivables | 36,324 | 35,589 |
Deferred revenue | $ 2,009,640 | $ 1,653,926 |
Revenue (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] | ||
Contract with customer, liability, revenue recognized | $ 609,500 | |
Revenue, remaining performance obligation, amount | 6,900,000 | |
Revenue, remaining performance obligation, non-cancellable, amount | $ 866,900 | |
Revenue, remaining performance obligation, excluding non-cancellable, recognized over twelve month period, percent | 41.00% | |
Capitalized contract cost, net | $ 96,800 | |
Amortization of capitalized costs to obtain revenue contracts | 16,737 | $ 15,008 |
Sales Based Royalties | ||
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] | ||
Contract with customer, liability, revenue recognized | $ 32,000 | $ 26,300 |
Business Combinations - Additional Information (Details) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Jan. 31, 2022
USD ($)
acquisition
|
Oct. 31, 2021
USD ($)
|
Jan. 31, 2021
USD ($)
|
|
Business Acquisition [Line Items] | |||
Number of businesses acquired | acquisition | 1 | ||
Consideration transfered | $ 20,000 | ||
Goodwill | 3,592,788 | $ 3,575,785 | |
Transaction costs | 2,100 | $ 3,500 | |
Series of Individually Immaterial Business Acquisitions | |||
Business Acquisition [Line Items] | |||
Identifiable intangibles assets acquired | 4,300 | ||
Goodwill | 15,700 | ||
Goodwill, expected tax deductible amount | $ 0 |
Goodwill and Intangible Assets - Changes of Goodwill (Details) $ in Thousands |
3 Months Ended |
---|---|
Jan. 31, 2022
USD ($)
| |
Goodwill [Roll Forward] | |
Beginning Balance | $ 3,575,785 |
Additions | 15,720 |
Adjustments | 1,285 |
Effect of foreign currency translation | (2) |
Ending Balance | $ 3,592,788 |
Goodwill and Intangible Assets - Estimated Future Amortization of Intangible Assets (Detail) $ in Thousands |
Jan. 31, 2022
USD ($)
|
---|---|
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |
Remainder of fiscal 2022 | $ 59,707 |
2023 | 64,851 |
2024 | 53,817 |
2025 | 37,653 |
2026 | 25,228 |
2027 and thereafter | 19,554 |
Total | $ 260,810 |
Balance Sheets Components - Components of Balance Sheet (Details) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Other long-term assets: | ||
Deferred compensation plan assets | $ 328,763 | $ 343,820 |
Capitalized commission, net | 96,848 | 92,249 |
Other long-term assets | 86,714 | 74,629 |
Total | 512,325 | 510,698 |
Accounts payable and accrued liabilities: | ||
Payroll and related benefits | 364,123 | 581,687 |
Other accrued liabilities | 147,407 | 132,091 |
Accounts payable | 29,203 | 27,413 |
Total | 540,733 | 741,191 |
Other long-term liabilities: | ||
Deferred compensation plan liabilities | 328,765 | 343,820 |
Other long-term liabilities | 51,370 | 47,613 |
Total | $ 380,135 | $ 391,433 |
Financial Assets and Liabilities - Additional Information (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Financial Assets and Liabilities [Line Items] | ||
Impairment of non-marketable equity securities | $ 0 | $ 0 |
Shipments period using hedges (in months) | 1 month | |
Period for hedge balance in OCI to be reclassified to statement of operations (in months) | 12 months | |
Non-Designated Hedging Instrument | ||
Financial Assets and Liabilities [Line Items] | ||
Forward contracts terms (in months) | 1 month | |
Foreign currency derivative contracts | Minimum | ||
Financial Assets and Liabilities [Line Items] | ||
Derivative maturity period | 1 month | |
Foreign currency derivative contracts | Maximum | ||
Financial Assets and Liabilities [Line Items] | ||
Derivative maturity period | 24 months | |
Foreign currency derivative contracts | Cash Flow Hedging | Maximum | ||
Financial Assets and Liabilities [Line Items] | ||
Derivative maturity period | 3 years | |
Foreign Exchange Forward | Cash Flow Hedging | Maximum | ||
Financial Assets and Liabilities [Line Items] | ||
Derivative maturity period | 24 months | |
Foreign Exchange Contracts | Maximum | ||
Financial Assets and Liabilities [Line Items] | ||
Duration of foreign exchange forward contracts | 1 year |
Financial Assets and Liabilities - Schedule of Maturity for Short-Term Available for Sale Securities (Details) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
|||
---|---|---|---|---|---|
Amortized Cost | |||||
less than 1 year | $ 53,374 | ||||
1-5 years | 88,847 | ||||
5-10 years | 4,268 | ||||
>10 years | 2,005 | ||||
Total | 148,494 | $ 148,195 | |||
Fair Value | |||||
less than 1 year | 53,269 | ||||
1-5 years | 88,261 | ||||
5-10 years | 4,249 | ||||
>10 years | 1,969 | ||||
Total | $ 147,748 | [1] | $ 147,949 | ||
|
Financial Assets and Liabilities - Short-term investments (Details) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
||||||
---|---|---|---|---|---|---|---|---|
Cash Equivalents [Line Items] | ||||||||
Total | $ 148,494 | $ 148,195 | ||||||
Gross Unrealized Gains | 7 | 13 | ||||||
Gross Unrealized Losses Less Than 12 Continuous Months | (753) | (259) | ||||||
Gross Unrealized Losses 12 Continuous Months or Longer | 0 | 0 | ||||||
Estimated fair value | 147,748 | [1] | 147,949 | |||||
Cash equivalents | ||||||||
Cash Equivalents [Line Items] | ||||||||
Total | 75,680 | 172,934 | ||||||
Gross Unrealized Gains | 0 | 0 | ||||||
Gross Unrealized Losses Less Than 12 Continuous Months | 0 | 0 | ||||||
Gross Unrealized Losses 12 Continuous Months or Longer | 0 | 0 | ||||||
Estimated fair value | 75,680 | [1] | 172,934 | [2] | ||||
Cash equivalents | Money market funds | ||||||||
Cash Equivalents [Line Items] | ||||||||
Total | 75,680 | 172,934 | ||||||
Gross Unrealized Gains | 0 | |||||||
Gross Unrealized Losses Less Than 12 Continuous Months | 0 | |||||||
Gross Unrealized Losses 12 Continuous Months or Longer | 0 | |||||||
Estimated fair value | 75,680 | [1] | 172,934 | [2] | ||||
Short-term investments | Corporate debt securities | ||||||||
Cash Equivalents [Line Items] | ||||||||
Total | 103,946 | 103,615 | ||||||
Gross Unrealized Gains | 5 | 7 | ||||||
Gross Unrealized Losses Less Than 12 Continuous Months | (537) | (170) | ||||||
Gross Unrealized Losses 12 Continuous Months or Longer | ||||||||
Estimated fair value | 103,414 | [1] | 103,452 | |||||
Short-term investments | U.S. government agency & T-bills | ||||||||
Cash Equivalents [Line Items] | ||||||||
Total | 8,095 | 6,447 | ||||||
Gross Unrealized Gains | 0 | |||||||
Gross Unrealized Losses Less Than 12 Continuous Months | (31) | (5) | ||||||
Gross Unrealized Losses 12 Continuous Months or Longer | ||||||||
Estimated fair value | 8,064 | [1] | 6,442 | |||||
Short-term investments | Municipal bonds | ||||||||
Cash Equivalents [Line Items] | ||||||||
Total | 3,946 | 4,588 | ||||||
Gross Unrealized Gains | 0 | |||||||
Gross Unrealized Losses Less Than 12 Continuous Months | (34) | (12) | ||||||
Gross Unrealized Losses 12 Continuous Months or Longer | ||||||||
Estimated fair value | 3,912 | [1] | 4,576 | |||||
Short-term investments | Asset-backed securities | ||||||||
Cash Equivalents [Line Items] | ||||||||
Total | 32,507 | 33,545 | ||||||
Gross Unrealized Gains | 2 | 6 | ||||||
Gross Unrealized Losses Less Than 12 Continuous Months | (151) | (72) | ||||||
Gross Unrealized Losses 12 Continuous Months or Longer | ||||||||
Estimated fair value | $ 32,358 | [1] | $ 33,479 | |||||
|
Financial Assets and Liabilities - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
Jan. 31, 2021 |
Oct. 31, 2020 |
---|---|---|---|---|
Cash and Cash Equivalents [Line Items] | ||||
Cash and cash equivalents | $ 1,124,299 | $ 1,432,840 | ||
Total cash, cash equivalents and restricted cash | 1,126,585 | 1,435,183 | $ 1,025,405 | $ 1,237,970 |
Restricted cash included in prepaid expenses and other current assets | ||||
Cash and Cash Equivalents [Line Items] | ||||
Restricted cash | 1,537 | 1,560 | ||
Restricted cash included in other long-term assets | ||||
Cash and Cash Equivalents [Line Items] | ||||
Restricted cash | $ 749 | $ 783 |
Financial Assets and Liabilities - Effects on Changes in Fair Values of Non-Designated Forward Contracts (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Financial Assets And Liabilities [Abstract] | ||
Gain (loss) recorded in other income (expense), net | $ 446 | $ 1,129 |
Financial Assets and Liabilities - Notional Amounts of Derivative Instruments (Detail) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Financial Assets And Liabilities [Abstract] | ||
Total gross notional amount | $ 1,179,091 | $ 1,176,152 |
Net fair value | $ 11,991 | $ 13,404 |
Financial Assets and Liabilities - Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Unaudited Condensed Consolidated Balance Sheet (Detail) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Designated As Hedging Instrument | Other current assets | ||
Financial Assets and Liabilities [Line Items] | ||
Fair values of derivative instruments, assets | $ 17,498 | $ 15,455 |
Designated As Hedging Instrument | Accrued liabilities | ||
Financial Assets and Liabilities [Line Items] | ||
Fair values of derivative instruments, liabilities | 5,556 | 2,027 |
Non-Designated Hedging Instrument | Other current assets | ||
Financial Assets and Liabilities [Line Items] | ||
Fair values of derivative instruments, assets | 57 | 17 |
Non-Designated Hedging Instrument | Accrued liabilities | ||
Financial Assets and Liabilities [Line Items] | ||
Fair values of derivative instruments, liabilities | $ 8 | $ 42 |
Financial Assets and Liabilities - Unaudited Condensed Consolidated Statement of Operations Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Financial Assets and Liabilities [Line Items] | ||
Total revenue | $ 1,270,255 | $ 970,321 |
Operating Expenses | 666,235 | 613,974 |
Net income | 313,687 | 162,345 |
Foreign Exchange Contracts | ||
Financial Assets and Liabilities [Line Items] | ||
Total revenue | (816) | (163) |
Operating Expenses | (769) | 4,256 |
Net income | (1,585) | 4,093 |
Foreign Exchange Contracts | Amount of gain (loss) reclassified from OCI (effective portion) | ||
Financial Assets and Liabilities [Line Items] | ||
Total revenue | (571) | 113 |
Operating Expenses | (274) | 2,613 |
Net income | $ (845) | $ 2,726 |
Fair Value Measures - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | $ 569,746 | $ 680,175 |
Total liabilities | 334,329 | 345,888 |
Deferred compensation plan liabilities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term liabilities | 328,765 | 343,820 |
Foreign currency derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Prepaid and other current assets | 17,555 | 15,472 |
Accounts payable and accrued liabilities | 5,564 | 2,068 |
Cash equivalents | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 75,680 | 172,934 |
Short-term investments | U.S. government agency & T-bills | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 8,064 | 6,442 |
Short-term investments | Municipal bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 3,912 | 4,576 |
Short-term investments | Corporate debt securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 103,414 | 103,452 |
Short-term investments | Asset-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 32,358 | 33,479 |
Deferred compensation plan assets | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term assets | 328,763 | 343,820 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | 404,443 | 516,754 |
Total liabilities | 328,765 | 343,820 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Deferred compensation plan liabilities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term liabilities | 328,765 | 343,820 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign currency derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Prepaid and other current assets | ||
Accounts payable and accrued liabilities | ||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash equivalents | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 75,680 | 172,934 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term investments | U.S. government agency & T-bills | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term investments | Municipal bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term investments | Corporate debt securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term investments | Asset-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Deferred compensation plan assets | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term assets | 328,763 | 343,820 |
Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | 165,303 | 163,421 |
Total liabilities | 5,564 | 2,068 |
Significant Other Observable Inputs (Level 2) | Deferred compensation plan liabilities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term liabilities | 0 | |
Significant Other Observable Inputs (Level 2) | Foreign currency derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Prepaid and other current assets | 17,555 | 15,472 |
Accounts payable and accrued liabilities | 5,564 | 2,068 |
Significant Other Observable Inputs (Level 2) | Cash equivalents | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | ||
Significant Other Observable Inputs (Level 2) | Short-term investments | U.S. government agency & T-bills | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 8,064 | 6,442 |
Significant Other Observable Inputs (Level 2) | Short-term investments | Municipal bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 3,912 | 4,576 |
Significant Other Observable Inputs (Level 2) | Short-term investments | Corporate debt securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 103,414 | 103,452 |
Significant Other Observable Inputs (Level 2) | Short-term investments | Asset-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | 32,358 | 33,479 |
Significant Other Observable Inputs (Level 2) | Deferred compensation plan assets | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term assets | ||
Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | 0 | 0 |
Total liabilities | 0 | 0 |
Significant Unobservable Inputs (Level 3) | Deferred compensation plan liabilities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term liabilities | 0 | |
Significant Unobservable Inputs (Level 3) | Foreign currency derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Prepaid and other current assets | ||
Accounts payable and accrued liabilities | ||
Significant Unobservable Inputs (Level 3) | Cash equivalents | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | ||
Significant Unobservable Inputs (Level 3) | Short-term investments | U.S. government agency & T-bills | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Significant Unobservable Inputs (Level 3) | Short-term investments | Municipal bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Significant Unobservable Inputs (Level 3) | Short-term investments | Corporate debt securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Significant Unobservable Inputs (Level 3) | Short-term investments | Asset-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term investments | ||
Significant Unobservable Inputs (Level 3) | Deferred compensation plan assets | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Other long-term assets |
Restructuring Charges - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | $ 11,746 | $ 0 |
2021 Restructuring Plan | ||
Restructuring Cost and Reserve [Line Items] | ||
Employee related restructuring liabilities | 21,000 | |
2021 Restructuring Plan | Severance and Termination | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | 11,700 | |
Cash payments | 4,900 | |
Restructuring and Related Cost, Cost Incurred to Date | $ 45,200 |
Credit and Term Loan Facilities - Additional Information (Detail) ¥ in Millions |
1 Months Ended | 3 Months Ended | |||
---|---|---|---|---|---|
Jul. 31, 2018
USD ($)
|
Jan. 31, 2022
USD ($)
|
Oct. 31, 2021
USD ($)
|
Jan. 22, 2021
USD ($)
|
Jul. 31, 2018
CNY (¥)
|
|
Foreign Line of Credit | |||||
Debt Instrument [Line Items] | |||||
Credit facility maximum borrowing capacity | $ 33,000,000 | ¥ 220.0 | |||
Borrowings, interest rate | 0.74% | ||||
Long-term line of credit, noncurrent | $ 24,300,000 | ||||
Fourth Amendment | Unsecured Debt | Term Loan | |||||
Debt Instrument [Line Items] | |||||
Credit facility maximum borrowing capacity | $ 97,500,000 | ||||
Long-term debt | 0 | ||||
Fourth Amendment | Unsecured Debt | Senior Revolving Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Credit facility maximum borrowing capacity | 650,000,000 | ||||
Fourth Amendment | Unsecured Debt | Uncommitted Incremental Loan Facility | |||||
Debt Instrument [Line Items] | |||||
Credit facility maximum borrowing capacity | $ 150,000,000 | ||||
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Current portion of line of credit | $ 0 | $ 0 | |||
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | Minimum | |||||
Debt Instrument [Line Items] | |||||
Commitment fees percentage | 0.125% | ||||
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | Maximum | |||||
Debt Instrument [Line Items] | |||||
Commitment fees percentage | 0.20% | ||||
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | |||||
Debt Instrument [Line Items] | |||||
Borrowings, interest rate | 1.00% |
Leases (Details) |
Jan. 31, 2022 |
---|---|
Maximum | |
Lessee, Lease, Description [Line Items] | |
Lessee, operating lease, renewal term | 10 years |
Leases - Components Of Lease Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||
---|---|---|---|---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|||||
Leases [Abstract] | ||||||
Operating lease expense | [1] | $ 22,032 | $ 23,626 | |||
Variable lease expense | [2] | 2,124 | 1,335 | |||
Total lease expense | $ 24,156 | $ 24,961 | ||||
|
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Leases [Abstract] | ||
Cash paid for amounts included in the measurement of operating lease liabilities | $ 20,620 | $ 20,644 |
ROU assets obtained in exchange for operating lease liabilities | $ 9,354 | $ 15,635 |
Leases - Lease Term And Discount Rate Information (Details) |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Leases [Abstract] | ||
Weighted-average remaining lease term (in years) | 7 years 9 months 21 days | 8 years |
Weighted-average discount rate | 1.99% | 2.01% |
Leases - Future Minimum Payments (Details) $ in Thousands |
Jan. 31, 2022
USD ($)
|
---|---|
Leases [Abstract] | |
Remainder of fiscal 2022 | $ 66,751 |
2023 | 85,113 |
2024 | 78,733 |
2025 | 67,235 |
2026 | 57,517 |
Thereafter | 246,530 |
Total future minimum lease payments | 601,879 |
Less: Imputed interest | 45,644 |
Total lease liabilities | $ 556,235 |
Leases - Lease Receipts (Details) $ in Thousands |
Jan. 31, 2022
USD ($)
|
---|---|
Leases [Abstract] | |
Remainder of fiscal 2022 | $ 12,737 |
2023 | 16,240 |
2024 | 13,788 |
2025 | 6,375 |
2026 | 6,566 |
Thereafter | 31,466 |
Total | $ 87,172 |
Accumulated Other Comprehensive Income (Loss) - Components of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands |
Jan. 31, 2022 |
Oct. 31, 2021 |
---|---|---|
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Accumulated other comprehensive income (loss) | $ (51,457) | $ (49,604) |
Cumulative currency translation adjustments | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Accumulated other comprehensive income (loss) | (48,660) | (48,047) |
Unrealized gain (loss) on derivative instruments, net of taxes | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Accumulated other comprehensive income (loss) | (2,051) | (1,311) |
Unrealized gain (loss) on available-for-sale securities, net of taxes | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Accumulated other comprehensive income (loss) | $ (746) | $ (246) |
Accumulated Other Comprehensive Income (Loss) - Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income (Detail) - Reclassification out of accumulated other comprehensive income (loss) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Reclassifications into net income | $ (845) | $ 2,726 |
Revenues | Gain (loss) on cash flow hedges, net of taxes | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Reclassifications into net income | (571) | 113 |
Operating expenses | Gain (loss) on cash flow hedges, net of taxes | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Reclassifications into net income | $ (274) | $ 2,613 |
Stock Repurchase Program - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
1 Months Ended | 3 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 |
Dec. 31, 2021 |
Jan. 31, 2022 |
Jan. 31, 2021 |
[3] | Dec. 10, 2021 |
||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Stock repurchase program authorized amount | $ 1,000,000 | ||||||||||||
Remaining amount available for further repurchases | $ 750,000 | ||||||||||||
Purchases of treasury stock (in shares) | 701 | [1],[2] | 837 | ||||||||||
Aggregate purchased shares | $ 245,000 | [1],[2] | $ 202,871 | ||||||||||
December 2021, ASR | |||||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Stock repurchase program authorized amount | $ 200,000 | ||||||||||||
Prepayment to repurchase stock | 200,000 | ||||||||||||
Initial share delivery | $ 160,000 | ||||||||||||
Purchases of treasury stock (in shares) | 200 | ||||||||||||
Purchases of treasury stock (in USD per share) | $ 331.37 | ||||||||||||
Aggregate purchased shares | $ 50,000 | ||||||||||||
December 2021, ASR | Subsequent Event | |||||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Stock repurchase program, prepayment during prior period, future derivative settlement | $ 40,000 | ||||||||||||
Purchases of treasury stock (in shares) | 600 | ||||||||||||
Purchases of treasury stock (in USD per share) | $ 331.09 | ||||||||||||
|
Stock Repurchase Program - Stock Repurchase Activities (Detail) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 |
Nov. 30, 2021 |
Mar. 31, 2021 |
Jan. 31, 2022 |
[1],[2] | Jan. 31, 2021 |
[3] | |||||||
Stock Repurchase Program [Abstract] | |||||||||||||
Purchases of treasury stock (in shares) | 701,000 | 837,000 | |||||||||||
Aggregate purchased shares | $ 245,000 | $ 202,871 | |||||||||||
Reissuance of treasury stock | 895,000 | 583,000 | |||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Share repurchases settlement of equity forward (in shares) | 107,701 | 166,726 | |||||||||||
Subsequent Event | |||||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Share repurchases settlement of equity forward (in shares) | 161,215 | ||||||||||||
December 2020, ASR | |||||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Stock repurchase program, prepayment during period, derivative settlement | $ 50,000 | ||||||||||||
December 2020, ASR | Subsequent Event | |||||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Stock repurchase program, prepayment during period, derivative settlement | $ 40,000 | ||||||||||||
August 2021, ASR | |||||||||||||
Accelerated Share Repurchases [Line Items] | |||||||||||||
Stock repurchase program, prepayment during period, derivative settlement | $ 35,000 | ||||||||||||
|
Stock-Based Compensation - Additional Information (Detail) $ in Millions |
3 Months Ended |
---|---|
Jan. 31, 2022
USD ($)
| |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unamortized share-based compensation expense | $ 945.9 |
Weighted-average period of total compensation costs to be recognized in years | 2 years 6 months |
ESPP | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unamortized share-based compensation expense | $ 35.9 |
Weighted-average period of total compensation costs to be recognized in years | 2 years |
Stock-Based Compensation - Stock Compensation Expense (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense before taxes | $ 95,771 | $ 83,782 |
Income tax benefit | (15,429) | (13,279) |
Stock-based compensation expense after taxes | 80,342 | 70,503 |
Cost of products | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense before taxes | 11,207 | 9,352 |
Cost of maintenance and service | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense before taxes | 4,583 | 3,335 |
Research and development expense | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense before taxes | 49,540 | 41,294 |
Sales and marketing expense | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense before taxes | 17,801 | 15,159 |
General and administrative expense | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense before taxes | $ 12,640 | $ 14,642 |
Stock-Based Compensation - Schedule of Intrinsic Value of Equity Awards Exercised (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Stock Compensation [Abstract] | ||
Intrinsic value of awards exercised | $ 112,925 | $ 40,524 |
Net Income per Share - Reconciliation of Weighted Average Common Shares Used to Calculate Basic Net Income Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Numerator: | ||
Net income attributed to Synopsys | $ 313,687 | $ 162,345 |
Denominator: | ||
Weighted-average common shares for basic net income per share (shares) | 153,218 | 152,498 |
Dilutive effect of potential common shares from equity-based compensation (shares) | 4,055 | 4,779 |
Weighted-average common shares for diluted net income per share (shares) | 157,273 | 157,277 |
Net income per share attributed to Synopsys: | ||
Basic (in USD per share) | $ 2.05 | $ 1.06 |
Diluted (in USD per share) | $ 1.99 | $ 1.03 |
Anti-dilutive employee stock-based awards excluded (shares) | 170 | 334 |
Segment Disclosure - Additional information (Detail) |
3 Months Ended |
---|---|
Jan. 31, 2022
Segment
| |
Segment Reporting [Abstract] | |
Number of reportable operating segment | 2 |
Segment Disclosure - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Segment Reporting Information [Line Items] | ||
Total revenue | $ 1,270,255 | $ 970,321 |
Adjusted operating income | 347,036 | 148,348 |
Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Adjusted operating income | $ 459,391 | $ 286,820 |
Adjusted operating margin | 36.00% | 30.00% |
Operating Segments | Semiconductor & System Design: | ||
Segment Reporting Information [Line Items] | ||
Total revenue | $ 1,162,695 | $ 878,368 |
Adjusted operating income | $ 447,392 | $ 278,876 |
Adjusted operating margin | 38.00% | 32.00% |
Operating Segments | Software Integrity: | ||
Segment Reporting Information [Line Items] | ||
Total revenue | $ 107,560 | $ 91,953 |
Adjusted operating income | $ 11,999 | $ 7,944 |
Adjusted operating margin | 11.00% | 9.00% |
Segment Disclosure - Schedule of Segment Reconciliation (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Segment Reporting Information [Line Items] | ||
Operating income | $ 347,036 | $ 148,348 |
Amortization of intangible expense | (23,112) | (21,314) |
Stock-based compensation expense | (95,771) | (83,782) |
Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Operating income | 459,391 | 286,820 |
Reconciling items: | ||
Segment Reporting Information [Line Items] | ||
Amortization of intangible expense | (22,360) | (20,276) |
Stock-based compensation expense | (95,771) | (83,782) |
Other | $ 5,776 | $ (34,414) |
Segment Disclosure - Revenues Related to Operations by Geographic Areas (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Schedule of Revenues from External Customers [Line Items] | ||
Total revenue | $ 1,270,255 | $ 970,321 |
United States | ||
Schedule of Revenues from External Customers [Line Items] | ||
Total revenue | 610,334 | 468,701 |
Europe | ||
Schedule of Revenues from External Customers [Line Items] | ||
Total revenue | 132,717 | 105,175 |
China | ||
Schedule of Revenues from External Customers [Line Items] | ||
Total revenue | 212,823 | 115,768 |
Korea | ||
Schedule of Revenues from External Customers [Line Items] | ||
Total revenue | 114,355 | 98,254 |
Other | ||
Schedule of Revenues from External Customers [Line Items] | ||
Total revenue | $ 200,026 | $ 182,423 |
Other Income (Expense), Net - Components of Other Income (Expense), Net (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Other Income (Expense) | ||
Interest income | $ 858 | $ 310 |
Interest expense | (500) | (739) |
Gain (loss) on assets related to deferred compensation plan | (19,599) | 30,866 |
Foreign currency exchange gain (loss) | (1,024) | (315) |
Other, net | 472 | (1,366) |
Total | $ (19,793) | $ 28,756 |
Income Taxes - Provision for Income Taxes and Effective Tax Rates (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jan. 31, 2022 |
Jan. 31, 2021 |
|
Income Tax Disclosure [Abstract] | ||
Income before income taxes | $ 327,243 | $ 177,104 |
Provision for income taxes | $ 13,902 | $ 15,076 |
Effective tax rate | 4.20% | 8.50% |
Income Taxes - Additional Information (Detail) - USD ($) |
1 Months Ended | 3 Months Ended | |
---|---|---|---|
Jul. 31, 2017 |
Jan. 31, 2022 |
Jan. 31, 2020 |
|
Taxes [Line Items] | |||
Statutory federal income tax rate | 21.00% | ||
Minimum | |||
Taxes [Line Items] | |||
Estimated potential decrease in underlying unrecognized tax benefits | $ 0 | ||
Maximum | |||
Taxes [Line Items] | |||
Estimated potential decrease in underlying unrecognized tax benefits | $ 45,000,000 | ||
Synopsys Hungary | Foreign Tax Authority | Tax Year 2011 - Tax Year 2013 | Hungarian Tax Authority | |||
Taxes [Line Items] | |||
Aggregate tax assessment | $ 25,000,000 | ||
Estimate of additional penalties and interest | $ 11,000,000 | ||
Unrecognized tax benefits | $ 17,400,000 |
$9X^)0OSXG=KPI_A^,4F7,R/>>$WDB^<$7^=I>)
M5C 9_T$DNX5D-Y/LU@W&T]N65V4<#[>M]@-"T2LH>LTH'E*F-%?1&WGD6ZET
M%1$NI57*$:)^0=1O1K3@*I1FG@8$9GMEBG"EPQSZY=.GFFEP4;!=-!PSQ<#<
MLH_F=+IPK16+$BQ?@X)I@.KLO^-I&'$R3^,E5U4LN(9E66W[ 8D!N1!HDO/3KQD[5L(1/X]5^(
M>.G'W4)$]R+]BLQU,3)7$D70C\HX(=*7(]+N.@ 799C.GSR1E3&_<5/RIQL6
M M'W85C?9Y%#[X95/'?3.(@?L)A?O5+%3XWF]ES;SP_#LN?>%YE
M+=C_>[X2*>1V!!O<2NX\X,!5["61(&_G29;M(^KG.^3CK[]04_N-W#['R3I[
MSEHE\NLO-J/6;W6A(!,LAB?XE,0'7A+G:1+"T /8FPLHJ[RM:0HUORE\MBE\
M5JK6>U2?NJ$;>^ [Y%I5K/O$S G8[%FJIM;?(Z98OK]>>>SF'P9VA+=&Y:=BAF$.FL
M]A6B"Z4AH:"00XTSN+OAK!>- 7 3@WNR@WUF0R]M-=,9*FU+](FM1(DVZ!D
M!13ZM@+HT0BXGK%Q.?N61 W'OO**9FR4%F,9Y/)FW$IM1F [@Q(F_!:W8T@I&SA-0 96<*,@[!!#I,R5,2R8*A.(HRR :AO&(QB0:^^!NTQ4,HVEL#Y/)Q(=[:1@G
M_3;%=)[X-(UGP^EX G_[1X(C$]:H"M=J-"G>"=/ZL=_MN]EY:^*7\+857C-5
M5$(#QYR@X=ET[(%JVTN[,+)QEMY*0PW"34OJR*AL )WG4IK#PB;H>_SZ#U!+
M P04 " ! A%)4R]5(2OT& !P$0 &0 'AL+W=O]#Q*%8.!\/V"J.HB\#\?J=
M:+L?X>'@R7VX1:]J?KPZZP+GSV/-0<5("&X0GNB#()[H)6& Z-31,.GI2,9H
MZ(S6?U-1">7@4>@> 7U03+B/B8Z:8YACYF*\FLA0FM#H'IWW+
?2^V_?;52E.]PJYVU [D>:JLO6F'):G>C(,G
MLZ#E3KP9+>^PF%]9K:F?*-9,,8&@$>6\YX@V&N I1PO3H>3=,3T*9YC1P2WW
MF"Y4IX8:(IY^K;VYUG:G*^DG2D169*(H,SIOFI8KUY'$0AQAX6\4!#H"8I$B
MALC3Q0+5S5]E;@&7.2FR3?T@'?QJ:V]M6)=64<<4FP&
M';E8R*RNW*C#(8S2UHUC4;3WN7 'D<:OF&*_)O#P9[[;8U2RSA.V;]O+W"M_A[F=[F^"D=,'
M[$Y9(980'?9GDQ[3_G;5_[%JY6XT%\I:5;K'7_J&D"OB\5N"[\(0/M%??E
M?P!02P,$% @ 0(125,8QF@)J P J0< !D !X;"]W;W)K 3\PO0B^&J(E;(-_[R =)S,?IG%RU5607UY?-[L9W%!Q?"@Z'ZM:J#/=:$C4
M#[Y3=0E.UR>